CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $195.81M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 1.31: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
195.81MUSDvs all stocks (USD)
Revenue (TTM)
127.48MUSDvs all stocks (USD)
Profit Margin
-36.59%vs Medical Devices peers
Beta
1.13xvs all stocks
52-Week Change
-65.25%vs all stocks
Market Capitalization
195.81MUSDvs all stocks (USD)
Enterprise Value
-13.32MUSDvs all stocks (USD)
Forward P/E
-8.25xvs Medical Devices peers
Price to Sales (TTM)
1.50xvs Medical Devices peers
Price to Book (MRQ)
0.6911xvs Medical Devices peers
Enterprise to Revenue
-0.1040xvs Medical Devices peers
Enterprise to EBITDA
0.2560xvs Medical Devices peers
Gross Margin
76.06%vs Medical Devices peers
Profit Margin
-36.59%vs Medical Devices peers
Operating Margin
-57.71%vs Medical Devices peers
Return on Assets (TTM)
-11.21%vs Medical Devices peers
Return on Equity (TTM)
-17.06%vs Medical Devices peers
Revenue (TTM)
127.48MUSDvs all stocks (USD)
Revenue per Share (TTM)
3.10USDUpdated Jul 9, 2026Quarterly Revenue Growth
-18.50%vs Medical Devices peers
Gross Profit (TTM)
98.18MUSDvs all stocks (USD)
EBITDA (TTM)
-52.02MUSDvs all stocks (USD)
Net Income (TTM)
-46.64MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-18.48%vs Medical Devices peers
Operating Cash Flow (TTM)
-17.57MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-969.25KUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 9, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
134.48MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
31.47MUSDFY2025 · Dec 31, 2025Gross Profit
103.01MUSDFY2025 · Dec 31, 2025Operating Income
-48.19MUSDvs all stocks (USD)
Pre-tax Income
-38.88MUSDFY2025 · Dec 31, 2025Income Tax Expense
66.00KUSDFY2025 · Dec 31, 2025Net Income
-38.94MUSDFY2025 · Dec 31, 2025EBIT
-38.86MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-35.59MUSDFY2025 · Dec 31, 2025Research & Development
38.55MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
112.65MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
9.33MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
19.00KUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-38.94MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-8.27MUSDFY2025 · Dec 31, 2025Free Cash Flow
-12.10MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
20.70MUSDFY2025 · Dec 31, 2025Income Tax Paid
58.00KUSDFY2025 · Dec 31, 2025Interest Paid
0.00USDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-38.94MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
3.27MUSDFY2025 · Dec 31, 2025Stock-based Compensation
31.61MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
6.66MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
627.00KUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-11.48MUSDFY2025 · Dec 31, 2025Capital Expenditures
-3.83MUSDFY2025 · Dec 31, 2025Purchase of Investments
-239.28MUSDFY2025 · Dec 31, 2025Sale of Investments
260.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
16.89MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-26.00KUSDFY2025 · Dec 31, 2025Other Financing Charges
-2.06MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
1.86MUSDFY2025 · Dec 31, 2025Shares Outstanding
41.38MSharesUpdated Jul 9, 2026Float Shares
39.18MSharesUpdated Jul 9, 2026Shares Short
4.17MSharesUpdated Jul 9, 2026Short Ratio
5.65daysvs all stocks
Short % of Shares Outstanding
10.64%vs all stocks
% Held by Insiders
5.66%vs all stocks
% Held by Institutions
93.04%vs all stocks
Total Cash (MRQ)
217.88MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
5.26USDUpdated Jul 9, 2026Total Debt (MRQ)
10.83MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0405xvs Medical Devices peers
Current Ratio (MRQ)
10.20xvs Medical Devices peers
Book Value per Share (MRQ)
6.68USDUpdated Jul 9, 2026Total Assets
311.81MUSDvs all stocks (USD)
Total Current Assets
287.46MUSDFY2025 · Dec 31, 2025Total Liabilities
36.13MUSDFY2025 · Dec 31, 2025Total Non-current Assets
24.36MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
9.88MUSDFY2025 · Dec 31, 2025Total Current Liabilities
26.25MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
19.95MUSDFY2025 · Dec 31, 2025Other Short-term Investments
208.18MUSDFY2025 · Dec 31, 2025Accounts Receivable
23.38MUSDFY2025 · Dec 31, 2025Inventory
31.56MUSDFY2025 · Dec 31, 2025Accounts Payable
5.30MUSDFY2025 · Dec 31, 2025Short-term Debt
1.16MUSDFY2025 · Dec 31, 2025Deferred Revenue
3.60MUSDFY2025 · Dec 31, 2025Other Current Liabilities
5.71MUSDFY2025 · Dec 31, 2025Long-term Debt
9.88MUSDFY2025 · Dec 31, 2025Common Stock (Book)
41.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-661.04MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
275.68MUSDvs all stocks (USD)
52-Week Low
4.48USDUpdated Jul 9, 202652-Week High
14.29USDUpdated Jul 9, 202652-Week Change
-65.25%vs all stocks
Beta
1.13xvs all stocks
50-Day MA
6.14USDUpdated Jul 9, 2026200-Day MA
8.38USDUpdated Jul 9, 2026Avg 10-Day Volume
879.72KSharesUpdated Jul 9, 2026Avg 30-Day Volume
869.76KSharesUpdated Jul 9, 2026Diluted EPS (TTM)
-1.13USDUpdated Jul 9, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.76Profit Margin: -0.37
Financial Health
Altman Z-Score 1.31: grey zoneSignificant
Altman Z-Score: 1.31
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $195.81M, lower than 95% of all stocks globallySignificant
Market cap (USD): 195,805,960Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
TaiGen Biopharmaceuticals Holdings Limited
Tier 1ProductionApproval-Gated PipelineRuleRisk
Sillajen Inc.
Tier 1ProductionApproval-Gated PipelineRule
ImmuneOncia Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
LENZ Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Minerva Neurosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Camp4 Therapeutics Corp.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Onward Medical
Tier 1ProductionApproval-Gated PipelineRule
Voyager Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Humedix Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tonix Pharmaceuticals Holding Corp.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Upi Semiconductor Corp.
1 interpretationLow-Leverage Liquidity Configuration
Jiangsu Hengli Hydraulic Co., Ltd.
1 interpretationLow-Leverage Liquidity Configuration
Shanghai Geoharbour Construction Group Co. Ltd.
1 interpretationLow-Leverage Liquidity Configuration